수신증 시장 규모, 점유율, 성장 분석 : 유형별, 적응증별, 진단별, 치료법별, 연령층별, 지역별 - 업계 예측(2026-2033년)

Global Hydronephrosis Market size was valued at USD 2.42 Billion in 2024 and is poised to grow from USD 2.54 Billion in 2025 to USD 3.78 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The rising incidence of urinary tract obstructions, such as kidney stones, congenital anomalies, and tumors, significantly propels the global hydronephrosis market. These obstructions lead to urine flow disruption, resulting in kidney swelling, tissue damage, and reduced renal function. As complications mount, there is a growing patient demand for diagnostic and therapeutic solutions, including minimally invasive techniques and surgical corrections. Contributing factors include shifting lifestyles, dietary choices, and an aging demographic, which increase the need for effective hydronephrosis management. Additionally, advancements in imaging technologies like ultrasound, CT scans, and MRI play a pivotal role, allowing for accurate and early diagnosis. This surge in diagnostic capabilities further enhances the demand for related medical devices and procedures, promoting overall market growth and investment potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hydronephrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hydronephrosis Market Segments Analysis

Global Hydronephrosis Market is segmented by Type, Indication, Diagnosis, Treatment, Age Group and region. Based on Type, the market is segmented into Unilateral hydronephrosis and Bilateral hydronephrosis. Based on Indication, the market is segmented into Intrinsic and Extrinsic. Based on Diagnosis, the market is segmented into Laboratory tests and Imaging. Based on Treatment, the market is segmented into Shock wave lithotripsy, Laparoscopy, Bladder catheterization, Steroid therapy and Other treatment types. Based on Age Group, the market is segmented into Adult and Pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hydronephrosis Market

The global hydronephrosis market is propelled by the rising prevalence of urinary tract obstructions, which encompass issues such as kidney stones, congenital abnormalities, and tumors. These medical conditions lead to the accumulation of urine, resulting in kidney swelling and compromised renal function. This growing health concern creates a significant demand for innovative diagnostic tools and effective therapeutic solutions, thereby stimulating market expansion across various regions. The urgent need to address these complications effectively fosters advancements in treatment methodologies and enhances the development of new technologies, contributing to the overall growth of the hydronephrosis market on a global scale.

Restraints in the Global Hydronephrosis Market

In numerous developing nations, insufficient awareness regarding kidney disorders coupled with a scarcity of early screening initiatives significantly impedes the timely diagnosis of hydronephrosis. This delay in detection not only diminishes the effectiveness of treatment options but also limits the overall demand for advanced diagnostic and therapeutic solutions. As a result, these factors present considerable obstacles to market growth in these areas, hindering the potential for widespread access to necessary care and intervention for those affected by hydronephrosis. Addressing these challenges is essential for fostering market expansion and improving health outcomes related to this condition.

Market Trends of the Global Hydronephrosis Market

The global hydronephrosis market is witnessing a significant trend towards pediatric care, emphasizing the need for addressing congenital urinary tract obstructions in infants and children. This shift is fueled by advancements in AI-assisted imaging technologies and early screening methods that enhance the accuracy of diagnosis and facilitate timely interventions. As healthcare providers prioritize long-term kidney health in the pediatric population, there is a growing demand for specialized diagnostic tools and tailored therapeutic solutions, thereby driving innovation and expanding market opportunities. This targeted approach not only improves patient outcomes but also supports the development of a robust pediatric hydronephrosis care ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hydronephrosis Market Size by Type & CAGR (2026-2033)

• Market Overview
• Unilateral hydronephrosis
• Bilateral hydronephrosis

Global Hydronephrosis Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Intrinsic
  • Acute unilateral obstructive uropathy
  • Kidney stone
  • Bladder cancer
  • Bladder stones
  • Urethral stricture
  • Pelvic organ prolapses
  • Other intrinsic indications
• Extrinsic
  • Retroperitoneal fibrosis
  • Ovarian vein syndrome
  • Other extrinsic indications

Global Hydronephrosis Market Size by Diagnosis & CAGR (2026-2033)

• Market Overview
• Laboratory tests
  • Urinalysis
  • Complete blood count
  • Electrolyte analysis
  • Other laboratory tests
• Imaging
  • Ultrasound
  • Intravenous pyelography
  • KUB X-Rays
  • CT-scan
  • Other imaging types

Global Hydronephrosis Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Shock wave lithotripsy
• Laparoscopy
• Bladder catheterization
• Steroid therapy
• Other treatment types

Global Hydronephrosis Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adult
• Pediatric

Global Hydronephrosis Market Size & CAGR (2026-2033)

• North America (Type, Indication, Diagnosis, Treatment, Age Group)
  • US
  • Canada
• Europe (Type, Indication, Diagnosis, Treatment, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Diagnosis, Treatment, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Diagnosis, Treatment, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Diagnosis, Treatment, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech (Germany/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations